Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Should patients with HPV-positive or negative tumors be treated differently?

George M.

Curr Oncol Rep. 2014 May;16(5):384. doi: 10.1007/s11912-014-0384-2. Review.

PMID:
24705915
2.

Clinical features and treatment strategy for HPV-related oropharyngeal cancer.

Okami K.

Int J Clin Oncol. 2016 Oct;21(5):827-835. Epub 2016 Jul 5. Review.

PMID:
27380170
3.

What is the best treatment for patients with human papillomavirus-positive and -negative oropharyngeal cancer?

Urban D, Corry J, Rischin D.

Cancer. 2014 May 15;120(10):1462-70. doi: 10.1002/cncr.28595. Epub 2014 Feb 27. Review.

4.

Staging and treatment of oropharyngeal cancer in the human papillomavirus era.

Ward MJ, Mellows T, Harris S, Webb A, Patel NN, Cox HJ, Piper K, Ottensmeier CH, Thomas GJ, King EV.

Head Neck. 2015 Jul;37(7):1002-13. doi: 10.1002/hed.23697. Epub 2014 Jul 12.

PMID:
24753272
5.

Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma.

Ang KK, Sturgis EM.

Semin Radiat Oncol. 2012 Apr;22(2):128-42. doi: 10.1016/j.semradonc.2011.12.004. Review.

PMID:
22385920
6.

HPV in oropharyngeal cancer: the basics to know in clinical practice.

Elrefaey S, Massaro MA, Chiocca S, Chiesa F, Ansarin M.

Acta Otorhinolaryngol Ital. 2014 Oct;34(5):299-309. Review.

7.

Oropharyngeal squamous cell carcinoma treatment: current standards and future directions.

Marur S, Burtness B.

Curr Opin Oncol. 2014 May;26(3):252-8. doi: 10.1097/CCO.0000000000000072. Review.

8.

Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis.

O'Sullivan B, Huang SH, Siu LL, Waldron J, Zhao H, Perez-Ordonez B, Weinreb I, Kim J, Ringash J, Bayley A, Dawson LA, Hope A, Cho J, Irish J, Gilbert R, Gullane P, Hui A, Liu FF, Chen E, Xu W.

J Clin Oncol. 2013 Feb 10;31(5):543-50. doi: 10.1200/JCO.2012.44.0164. Epub 2013 Jan 7.

PMID:
23295795
9.

Absent/weak CD44 intensity and positive human papillomavirus (HPV) status in oropharyngeal squamous cell carcinoma indicates a very high survival.

Näsman A, Nordfors C, Grün N, Munck-Wikland E, Ramqvist T, Marklund L, Lindquist D, Dalianis T.

Cancer Med. 2013 Aug;2(4):507-18. doi: 10.1002/cam4.90. Epub 2013 Jun 14.

10.

HPV-positive head and neck tumours, a distinct clinical entity.

Nevens D, Nuyts S.

B-ENT. 2015;11(2):81-7. Review.

PMID:
26563006
11.

Is treatment de-escalation a reality in HPV related oropharyngeal cancer?

Oosthuizen JC, Kinsella JB.

Surgeon. 2016 Aug;14(4):180-3. doi: 10.1016/j.surge.2016.04.002. Epub 2016 May 15. Review.

PMID:
27188245
12.

High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.

Licitra L, Perrone F, Bossi P, Suardi S, Mariani L, Artusi R, Oggionni M, Rossini C, Cantù G, Squadrelli M, Quattrone P, Locati LD, Bergamini C, Olmi P, Pierotti MA, Pilotti S.

J Clin Oncol. 2006 Dec 20;24(36):5630-6.

PMID:
17179101
13.

HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation.

van Kempen PM, van Bockel L, Braunius WW, Moelans CB, van Olst M, de Jong R, Stegeman I, van Diest PJ, Grolman W, Willems SM.

Cancer Med. 2014 Oct;3(5):1185-96. doi: 10.1002/cam4.313. Epub 2014 Jul 26.

14.

Human papillomavirus-associated oropharynx cancer (HPV-OPC): treatment options.

Chau NG, Rabinowits G, Haddad RI.

Curr Treat Options Oncol. 2014 Dec;15(4):595-610. doi: 10.1007/s11864-014-0309-1. Review.

PMID:
25240410
15.

Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas.

Horne ZD, Glaser SM, Vargo JA, Ferris RL, Balasubramani GK, Clump DA, Heron DE, Beriwal S.

Cancer. 2016 Jul 1;122(13):2021-30. doi: 10.1002/cncr.30021. Epub 2016 Apr 25.

16.

Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality?

Fischer CA, Zlobec I, Green E, Probst S, Storck C, Lugli A, Tornillo L, Wolfensberger M, Terracciano LM.

Int J Cancer. 2010 Mar 1;126(5):1256-62. doi: 10.1002/ijc.24842.

17.

Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas.

Sedaghat AR, Zhang Z, Begum S, Palermo R, Best S, Ulmer KM, Levine M, Zinreich E, Messing BP, Gold D, Wu AA, Niparko KJ, Kowalski J, Hirata RM, Saunders JR, Westra WH, Pai SI.

Laryngoscope. 2009 Aug;119(8):1542-9. doi: 10.1002/lary.20533.

PMID:
19522004
18.

HPV-associated head and neck cancer: a virus-related cancer epidemic.

Marur S, D'Souza G, Westra WH, Forastiere AA.

Lancet Oncol. 2010 Aug;11(8):781-9. doi: 10.1016/S1470-2045(10)70017-6. Epub 2010 May 5. Review.

20.

Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer.

Wagner S, Wittekindt C, Sharma SJ, Wuerdemann N, Jüttner T, Reuschenbach M, Prigge ES, von Knebel Doeberitz M, Gattenlöhner S, Burkhardt E, Pons-Kühnemann J, Klussmann JP.

Br J Cancer. 2017 Jun 6;116(12):1604-1611. doi: 10.1038/bjc.2017.132. Epub 2017 May 4.

PMID:
28472822

Supplemental Content

Support Center